Ad Header

PharmaLive

Slogan

The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

GSK to change incentives for sales representatives

GlaxoSmithKline will change incentives for sales representatives in some countries as the British drugmaker looks to retain talent.

Read More »

New Tool Allows View of Cell Division in 3D Models

The Allen Institute for Cell Science launched the Integrated Mitotic Stem Cell, a new tool that visualizes mitosis.

Read More »

Amgen to buy Copenhagen-based Nuevolution

Amgen Inc.’s drug discovery position will be boosted after agreeing to buy Scandinavian biopharmaceutical company Nuevolution AB for 1.61 billion Swedish crowns ($166.8 million).

Read More »

Evotec Diversifies into Biologics with $90 Million Acquisition of Just Biotherapeutics

Germany-based Evotec SE followed up a string of collaborations with pharma companies with the $90 million acquisition of Bill & Melinda Gates Foundation-backed Just Biotherapeutics Inc.

Read More »

Alphabet’s Verily Inks Collaboration Deal with Big Pharma Companies and Health Systems

Verily announced a strategic collaboration deal with Novartis, Otsuka, Pfizer, Sanofi, and six major health systems.

Read More »

Shares of BioCryst Fall After Phase III HAE Drug Underwhelms Investors

Shares of North Carolina-based BioCryst Pharmaceuticals were down more than 53 percent after the company released data from a Phase III trial that underwhelmed analysts.

Read More »

Mallinckrodt sues U.S. health agencies, sees 10% hit to MS treatment sales

Mallinckrodt Plc filed a lawsuit against the U.S. Department of Health and Human Services and forecast an about 10 percent hit to annual net sales of the company’s gel used to treat multiple sclerosis symptoms following changes to Medicaid rebate calculations, sending shares plunging as much as 34 percent.

Read More »

Merck buys Peloton, expands kidney cancer treatment portfolio

U.S. drugmaker Merck & Co. Inc. agreed to buy Peloton Therapeutics Inc. for $1.05 billion in cash, gaining access to the privately held company’s lead kidney cancer drug candidate.

Read More »

Dana-Farber Scientists Win Checkpoint Inhibitor Patent Lawsuit

Vaunted immunotherapy pioneers from the Dana-Farber Cancer Institute won a key court case that could be worth billions of dollars.

Read More »

U.S. Supreme Court tosses ruling against Merck on Fosamax osteoporosis drug

The U.S. Supreme Court on Monday handed a victory to Merck & Co. – at least for now – by throwing out a lower court ruling that had revived hundreds of lawsuits accusing the company of failing to properly warn patients of debilitating thigh-bone fractures from taking the osteoporosis drug Fosamax.

Read More »

Ad Right Top

MedAdNews

Extensive pharmaceutical business and marketing intelligence. For back issues, please contact MDAD@kmpsgroup.com.

April 2019 Focus: Healthcare agency & network profiles, industry overview & awards, and more!

Subscribe

Ad Right Bottom